U.S. vaccinations started dropping during the Johnson & Johnson pause. Did Biden's team mess up?
The U.S. halted use of Johnson & Johnson's one-dose COVID-19 vaccine on April 13 to study extremely rare cases of serious blood clots in a handful of vaccinated Americans, mostly women under 50, then lifted the stay 10 days later. The U.S. had built up to more than 3.3. million shots per day by April 13, but those numbers started dropping during the Johnson & Johnson pause for all three approved vaccines. The seven-day average is now 2.02 million shots a day, The Washington Post reports.
White House coronavirus response coordinator Jeff Zients said on CNN Sunday that it was "not at all" a mistake for the Food and Drug Administration to suspend Johnson & Johnson vaccinations, and in fact it helped build confidence in oversight of the vaccines. "Doing the pause was the right thing," he argued.
While most of the world is struggling to get enough vaccine to meet demand, in the U.S., "states asked the federal government this week to withhold staggering amounts of COVID-19 vaccine amid plummeting demand for the shots, contributing to a growing U.S. stockpile of doses," The Associated Press reports. The slowing vaccination rate in the U.S., combined with more contagious variants, has led public health experts to conclude that vanquishing the coronavirus through herd immunity is now unlikely, in the U.S. — where vaccine hesitancy is high — or the world.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Popular vectors of vaccine misinformation may be feeding hesitancy in some groups, and, The Wall Street Journal notes, "more than four months into the vaccination campaign, many of the people willing to get vaccinated have done so." But there is anecdotal evidence that the Johnson & Johnson halt was "the straw that broke the camel's back" for people already leery of getting vaccinated, as Paul Shelton at health-tech company AdhereHealth told the Journal. On the other hand, some officials involved in the U.S. vaccination effort also say there are groups that will only agree to getting Johnson & Johnson's one-and-done shot.
And there are lots of people still on the fence. "We can sometimes underestimate how thoughtful people can be about their decisions and what can look reactionary can sometimes just be people taking their time and thinking," Kimberly Hood, assistant secretary for the Louisiana Department of Health's office of public health, told the Journal.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The teenage 'maths prodigy' who turned out to be a cheat
Under The Radar Jiang Ping defied expectations in a global competition but something wasn't right
By Chas Newkey-Burden, The Week UK Published
-
Puppet shows, pagodas and pho: a guide to Hanoi
The Week Recommends Vietnam's capital city blends the ancient with the new
By Catherine Garcia, The Week US Published
-
'There are benefits, but not acknowledging them would tell only half of the story'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Boeing machinists approve contract, end strike
Speed Read The company's largest union approved the new contract offer, ending a seven-week strike
By Peter Weber, The Week US Published
-
US economy still strong in final preelection report
Speed Read It grew at a solid 2.8% annual rate from July through September
By Peter Weber, The Week US Published
-
Boeing machinists reject deal, continue strike
Speed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
By Peter Weber, The Week US Published
-
Ports reopen after dockworkers halt strike
Speed Read The 36 ports that closed this week, from Maine to Texas, will start reopening today
By Peter Weber, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published